Status:
UNKNOWN
MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
Bioxydyn Ltd, Manchester
University Hospital, Basel, Switzerland
Conditions:
Cystic Fibrosis
Primary Ciliary Dyskinesia
Eligibility:
All Genders
6+ years
Brief Summary
This is a small pilot / feasibility study (Approximately 50 patients) to assess the possibility of clinical implementation of MRI assessment of patients with cystic fibrosis and primary ciliary dyskin...
Detailed Description
In this small single site pilot / feasibility study we aim to recruit approximately 50 patients over the age of 6 years with known cystic fibrosis (CF) or primary ciliary dyskinesia (PCD). Patients w...
Eligibility Criteria
Inclusion
- Known CF or PCD Referred for CT chest
Exclusion
- Contraindication to MRI (Pacemaker etc) Unable to stay still for MRI
Key Trial Info
Start Date :
May 5 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 5 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03279965
Start Date
May 5 2017
End Date
May 5 2018
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital
London, United Kingdom, SW3 6NP